We are interested in trauma and its comorbidities (e.g. affective disorders, addiction, metabolic dysfunction, neurodegeneration). Using an iterative translation approach, we utilize both human and animal populations and focus on reciprocal connections between the brain and peripheral organs (e.g. liver, gut) in order to understand adverse outcomes of trauma from a holistic systems biology standpoint. We are especially interested in understanding the role of monoamines (e.g. dopamine, serotonin) and neuromodulators (e.g. opioids, cytokines). We utilize computational medicine approaches (e.g. machine learning, big data, electronic medical records, biomarkers) and are committed to open source science.
Current Projects:
Mapping individual differences in the polytrauma clinical triad to substance use risk: a pilot study
Neural Mechanisms of Impulsivity and Attention Following Traumatic Brain Injury
Understanding Chronic Health Outcomes and COVID-19 Risk Among OEF/OIF/OND Veterans